Genetic association study of interferon lambda 3, CD27, and human leukocyte antigen-DPB1 with dengue severity in Thailand

[1]  J. Ohashi,et al.  Interferon lambda 1 is associated with dengue severity in Thailand. , 2020, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[2]  Vargas-CastilloAngélica Berenice,et al.  Association of Single-Nucleotide Polymorphisms in Immune-Related Genes with Development of Dengue Hemorrhagic Fever in a Mexican Population. , 2017 .

[3]  Carlos F. Narváez,et al.  B cells naturally induced during dengue virus infection release soluble CD27, the plasma level of which is associated with severe forms of pediatric dengue. , 2016, Virology.

[4]  D. Tyrrell,et al.  The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections , 2014, Emerging Microbes & Infections.

[5]  Hongbing Shen,et al.  New loci associated with chronic hepatitis B virus infection in Han Chinese , 2013, Nature Genetics.

[6]  H. Shin,et al.  A genome-wide association study identified new variants associated with the risk of chronic hepatitis B. , 2013, Human molecular genetics.

[7]  E. Marques,et al.  HLA-B∗44 Is Associated with Dengue Severity Caused by DENV-3 in a Brazilian Population , 2013, Journal of tropical medicine.

[8]  S. Halstead,et al.  Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection , 2013, Archives of Virology.

[9]  A. Kim,et al.  IL28B polymorphisms as a pretreatment predictor of response to HCV treatment. , 2012, Infectious disease clinics of North America.

[10]  A. Koike,et al.  Genome-Wide Association Study Confirming Association of HLA-DP with Protection against Chronic Hepatitis B and Viral Clearance in Japanese and Korean , 2012, PloS one.

[11]  M. Imamura,et al.  Genetics of IL28B and HCV—response to infection and treatment , 2012, Nature Reviews Gastroenterology &Hepatology.

[12]  Richard Apps,et al.  A Novel Variant Marking HLA-DP Expression Levels Predicts Recovery from Hepatitis B Virus Infection , 2012, Journal of Virology.

[13]  D. Pang,et al.  Association of CD27 and CD70 gene polymorphisms with risk of sporadic breast cancer in Chinese women in Heilongjiang Province , 2012, Breast Cancer Research and Treatment.

[14]  Robert M. Plenge,et al.  Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis , 2011, Nature Genetics.

[15]  K. Hirayama,et al.  Host genetic susceptibility to severe dengue infection , 2011, Tropical medicine and health.

[16]  Y. Kamatani,et al.  A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population. , 2011, Human molecular genetics.

[17]  Cameron P Simmons,et al.  The pathogenesis of dengue. , 2011, Vaccine.

[18]  Julia E. Vogt,et al.  Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C. , 2011, Gastroenterology.

[19]  A. Neumann,et al.  Response Prediction in Chronic Hepatitis C by Assessment of IP-10 and IL28B-Related Single Nucleotide Polymorphisms , 2011, PloS one.

[20]  B. Clotet,et al.  IL28B SNP rs8099917 Is Strongly Associated with Pegylated Interferon-α and Ribavirin Therapy Treatment Failure in HCV/HIV-1 Coinfected Patients , 2010, PloS one.

[21]  M. Xiong,et al.  HLA-DPB1 and DPB2 are genetic loci for systemic sclerosis: a genome-wide association study in Koreans with replication in North Americans. , 2009, Arthritis and rheumatism.

[22]  David B. Goldstein,et al.  Genetic variation in IL28B and spontaneous clearance of hepatitis C virus , 2009, Nature.

[23]  A. Koike,et al.  Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C , 2009, Nature Genetics.

[24]  Thomas Berg,et al.  IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy , 2009, Nature Genetics.

[25]  Y. Kamatani,et al.  A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians , 2009, Nature Genetics.

[26]  Tom R. Gaunt,et al.  Practice of Epidemiology Hardy-Weinberg Equilibrium Testing of Biological Ascertainment for Mendelian Randomization Studies , 2009 .

[27]  K. Morita,et al.  Protective and Enhancing HLA Alleles, HLA-DRB1*0901 and HLA-A*24, for Severe Forms of Dengue Virus Infection, Dengue Hemorrhagic Fever and Dengue Shock Syndrome , 2008, PLoS neglected tropical diseases.

[28]  K. Goddard,et al.  Genetic ancestry and income are associated with dengue hemorrhagic fever in a highly admixed population , 2008, European Journal of Human Genetics.

[29]  B. Murphy,et al.  Prospects for a dengue virus vaccine , 2007, Nature Reviews Microbiology.

[30]  Phyllis Kanki,et al.  HLA-A, -B, -C, and -DRB1 allele frequencies in Cuban individuals with antecedents of dengue 2 disease: advantages of the Cuban population for HLA studies of dengue virus infection. , 2007, Human immunology.

[31]  M. Guzmán,et al.  Race: a risk factor for dengue hemorrhagic fever , 2006, Archives of Virology.

[32]  J. Borst,et al.  CD27 and CD70 in T cell and B cell activation. , 2005, Current opinion in immunology.

[33]  F. Chiodi,et al.  Effects of potent antiretroviral therapy on the immune activation marker soluble CD27 in patients infected with HIV‐1 subtypes A–D , 2004, Journal of medical virology.

[34]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[35]  J. Bijlsma,et al.  Th2 mediated regulation in RA and the spondyloarthropathies , 2002, Annals of the rheumatic diseases.

[36]  C. Villarreal-Garza,et al.  HLA-DR antigen frequencies in Mexican patients with dengue virus infection: HLA-DR4 as a possible genetic resistance factor for dengue hemorrhagic fever. , 2002, Human immunology.

[37]  A. Nisalak,et al.  HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais. , 2002, Tissue antigens.

[38]  F. Chiodi,et al.  Plasma levels of soluble CD27: a simple marker to monitor immune activation during potent antiretroviral therapy in HIV‐1‐infected subjects , 2002, Clinical and experimental immunology.

[39]  A. Mustafa,et al.  Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis. , 2000, FEMS immunology and medical microbiology.

[40]  A. Nisalak,et al.  Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. , 2000, The Journal of infectious diseases.